Company Encyclopedia
View More
name
SBC Medical
SBC.US
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; facility rental services; construction and design services for franchisee clinics; and medical consumables procurement services. It also provides program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods.
384.02 B
SBC.USMarket value -Rank by Market Cap -/-

Financial Score

22/11/2025 Update
C
Health Care ServicesIndustry
Industry Ranking39/80
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE19.13%A
    • Profit Margin24.28%A
    • Gross Margin70.61%A
  • Growth ScoreD
    • Revenue YoY-20.10%E
    • Net Profit YoY-20.38%D
    • Total Assets YoY8.39%B
    • Net Assets YoY20.70%A
  • Cash ScoreD
    • Cash Flow Margin411.92%C
    • OCF YoY-20.10%E
  • Operating ScoreB
    • Turnover0.58B
  • Debt ScoreA
    • Gearing Ratio22.81%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Boss Zhipin: Not Surprising, but Still Strong

    $BOSS ZHIPIN-W(02076.HK) $Kanzhun(BZ.US) Q3 financial report has been released, and the overall performance basically met expectations. It is still the same BOSS—despite still facing pressure, the company's ability to outperform Beta is still evident. Specifically: 1. Billings showed signs of recovery: Q3 billings increased by 14% year-on-year, showing a significant recovery compared to the previous quarter. Although this was within expectations and last year's base was low, it is commendable to withstand the pressure in a relatively high-pressure environment...

    HK
    02076
    -3.16%
    US
    SBC
    +6.60%
    DE
    BOSS
    0.00%
    HK
    02076
    -3.16%
    US
    SBC
    +6.60%
    DE
    BOSS
    0.00%

    SBC Medical | 10-Q: FY2025 Q3 Revenue: USD 43.35 M

    LB filings·
    US
    SBC
    +6.60%
    LB filings·
    US
    SBC
    +6.60%

    SBC Medical | 8-K: FY2025 Q3 Revenue: USD 43.35 M

    LB filings·
    US
    SBC
    +6.60%
    LB filings·
    US
    SBC
    +6.60%

    Tencent: Not playing heartbeats with Meta, just seeking stable happiness

    After the Hong Kong stock market closed on November 13, Beijing time, $TENCENT(00700.HK) released its third-quarter 2025 results. Overall, while there were not many surprises compared to expectations, stability remains the key theme, with no significant weaknesses in the three major business lines. Since the beginning of this year, Tencent has entered a new investment cycle, yet traces of the management's refined operations and effective capital allocation can still be observed. Specifically: 1. Gaming remains the standout: Tencent Games maintained high growth of 23% in the third quarter, driven by the product cycle. Overseas, under the leadership of Supercell's 'Clash Royale,' it continued to surge (with favorable exchange rate contributions)...

    HK
    00700
    -1.77%
    US
    GOOG
    +3.33%
    US
    GOOGL
    +3.53%
    HK
    00700
    -1.77%
    US
    GOOG
    +3.33%
    US
    GOOGL
    +3.53%

    BEKE: Is there still hope?

    Leading domestic housing intermediary--$KE(BEKE.US) announced its Q3 2025 results on the evening of November 10th before the US stock market opened. Overall, the performance can be summarized as "not good, but not as bad as feared." Additionally, due to the recent significant pullback in the company's stock price, the low expectations implied by the relatively low stock price have led to some bottoming out and recovery. Specifically: 1. Revenue is still supportive, but profits are deeply underwater: In terms of overall performance, although the core intermediary business revenue experienced negative growth in the sluggish real estate market, it was offset by the strong performance of the slightly "bloated" rental business...

    HK
    02423
    -1.96%
    US
    SBC
    +6.60%
    US
    BEKE
    +2.82%
    HK
    02423
    -1.96%
    US
    SBC
    +6.60%
    US
    BEKE
    +2.82%
    Posts
    View More

    Beike 3Q25 Quick Interpretation: Overall, Beike's performance this quarter can be summarized as "not good, but not as bad as feared."

    Due to the recent general decline in U.S. stocks, the company's sh...

    • 0